August 2001 • Volume 7 • Number 8
Protect physicians from lawsuits over drugs withdrawn from market
At AAFP's request, the AMA is now committed to seeking a law exempting physicians from liability in class action lawsuits over drugs withdrawn from the market.
Delegate Dale Moquist, M.D., of Bryan, Texas, spoke at the AMA House of Delegates in support of an AAFP resolution calling for the new legislation. He said involvement in lawsuits "has been a problem for many of our members who have prescribed FDA-approved medicines. After they're prescribed, they're being taken off the market, Rezulin being one."
In an interview, Moquist said AAFP members are also defending themselves for prescribing Redux and fenfluramine when those drugs were still FDA-approved. The AMA house, which met in Chicago in June, adopted the AAFP resolution.
FP Report is published by the AAFP News Department.
Copyright © 2001 by American Academy of Family Physicians.
FP Report | Headlines |AAFP Home | Search